Paragon 28 Launches R3ACT Ankle Stabilization

Paragon 28 introduced its R3ACT™ Stabilization System, designed to allow for multi-stage soft tissue healing following an acute or chronic syndesmotic injury to the ankle.

The system received FDA 510(k) marketing clearance in January 2022.

Paragon 28’s CEO, Albert DaCosta, said, “Since the inception of Paragon 28, the development of a...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

  • This field is for validation purposes and should be left unchanged.

0